Phillips 66 Partners (NYSE: PSXP) launched on July 23 as one of the most anticipated IPOs this year. PSXP owns some of the midstream logistics assets of its sponsor, Phillips 66 (NYSE: PSX). PSXP has yet to announce its first distribution, but according to the IPO prospectus the minimum yield will be $0.85 per unit on an annualized basis. At the current unit price, this equates to a minimum annual yield of 2.8 percent, which is mainly a function of the huge run-up in unit price between the IPO pricing and today’s unit price. If the distribution does come in near the minimum, the unit price will almost certainly correct downward following the announcement.
Marlin Midstream Partners (Nasdaq: FISH) launched on July 26. The partnership provides natural gas gathering, transportation, treating and processing services, NGL transportation services and crude oil transloading services. Marlin’s assets include three natural gas processing facilities in Texas, two natural gas gathering systems, two NGL transportation pipelines, and two crude oil transloading facilities. Marlin expects most of the gross margin to be generated under fee-based, minimum volume commercial agreements.
Marlin targets a coverage ratio of 1.10x to support distributions. Marlin’s partnership agreement provides for a minimum quarterly distribution of $0.35 per unit for each whole quarter, or $1.40 per unit on an annualized basis. The prorated distribution for the two months of the recently concluded quarter since tje IPO should be announced soon. The minimum annual yield based on the current unit price is projected at 7.7 percent. The unit price has declined 6 percent since the IPO.
Hot Restaurant Stocks To Buy Right Now: United States Steel Corporation(X)
United States Steel Corporation produces and sells steel mill products in North America and Central Europe. It operates in three segments: Flat-rolled Products (Flat-rolled), U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-rolled segment offers slabs, rounds, strip mill plates, sheets, and tin mill products, as well as iron ore and coke. This segment serves service center, conversion, transportation, construction, container, and appliance and electrical markets in North America. The USSE segment offers slabs, sheets, strip mill plates, tin mill products, and spiral welded pipes, as well as heating radiators and refractory ceramic materials. This segment serves the European construction, service center, conversion, container, transportation, and appliance and electrical, as well as and oil, gas, and petrochemical markets. The Tubular segment offers seamless and electric resistance welded steel casing and tubing; and standard, and line pipe and mechanical tubing. It primarily serves customers in the oil, gas, and petrochemical markets. The company also provides transportation services, including railroad and barge operations. In addition, it owns, develops, and manages various real estate assets, which include approximately 200,000 acres of surface rights primarily in Alabama, Illinois, Maryland, Michigan, Minnesota, and Pennsylvania; participates in joint ventures that are developing real estate projects in Alabama, Maryland, and Illinois; and owns approximately 4,000 acres of land in Ontario, Canada. The company was founded in 1901 and is headquartered in Pittsburgh, Pennsylvania.
Advisors' Opinion:- [By Ben Levisohn]
Investors, however, are showing no signs of letting up on the risk taking. Want evidence? Just look at the top-performing stocks this week. Four of the top-five come from the materials sector, which could benefit from a stronger economy.�Cliffs Natural Resources (CLF), which rose 9.6% this week, Allegheny Technologies (ATI), which gained 7.7%, U.S. Steel (X), which advanced 7.7%, and Dow-exile Alcoa (AA), which finished the week up 7.6% They were joined by PulteGroup (PHM), which rose 7.8% after a delay of a Fannie Mae and Freddie Mac mortgage-fee hike was mooted.
- [By Alex Planes]
The day's most notable gain was that of non-Dow stock Auburn Automobile, which skyrocketed 40% due to what would later be revealed as stock manipulation by Auburn owner Errett Cord (the company's tiny float made it highly susceptible to such meddling). Many Dow components rose as well, with industrial bellwether U.S. Steel (NYSE: X ) advancing despite reports that its unfilled orders had fallen further than expected. This drop was waved off by The New York Times, which blamed "seasonal tendencies" for the 150,000-ton order decline. Its strong performance in spite of the purportedly bad news helped drag many of its Dow peers along for the ride.
- [By Alex Planes]
The first Morgan megadeal actually took place in 1892, when he brought Thomas Edison's company together with several other leading electric ventures to form General Electric (NYSE: GE ) . Morgan's greatest triumph came in 1901, when he formed U.S. Steel (NYSE: X ) , the first billion-dollar company in American history. A year later, Morgan merged farm-implement pioneer McCormick with other agricultural equipment companies to create International Harvester, the predecessor of Navistar.�All three of these companies held spots on the Dow Jones Industrial Average (DJINDICES: ^DJI ) for decades at a time, which -- when including JPMorgan Chase itself -- makes J.P. Morgan the only businessman in American history directly responsible for the creation of four Dow components, past or present.
Best Logistics Stocks To Own Right Now: Saratoga Investment Corp(SAR)
Saratoga Investment Corp. is a business development company specializing in buyout, acquisition, growth, recapitalization, and note financing transactions of private middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. It seeks to invest in the United States. The firm primarily invests in companies having EBITDA between $5 million and $50 million. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. is based in New York, New York with an additional office in Florham Park, New Jersey.
Advisors' Opinion:- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Citigroup Inc. (NYSE: C), Saratoga Investment Corp. (NYSE: SAR), Bank of the Ozarks (NASDAQ: OZRK) Economic Releases Expected: Japanese industrial production, eurozone industrial productionTuesday
Best Logistics Stocks To Own Right Now: Home Loan Servicing Solutions Ltd (HLSS)
Home Loan Servicing Solutions, Ltd, incorporated on December 1, 2010, is a development-stage company. The Company is formed to acquire mortgage servicing assets, primarily subprime and Alt-A mortgage servicing rights and associated servicing advances. The Company will engage residential mortgage loan servicers to service the pools of mortgage loans underlying the mortgage servicing rights. The Company acquire and therefore do not intend to develop its own mortgage servicing platform.
The Company is focused to enter into the subservicing agreement to provide for the servicing of the initial mortgage servicing rights for an initial term of seven years. As of December 31, 2010, The Company had neither purchased nor contracted to purchase any mortgage servicing assets, including mortgage servicing rights and related servicing advances.
Advisors' Opinion:- [By Eric Volkman]
Home Loan Servicing Solutions (NASDAQ: HLSS ) is servicing its capital base with a new share offering that should total nearly $300 million. The company is floating 13 million shares of its stock in an underwritten public issue at a price of $23 per share. All told, the gross proceeds of the offering should amount to roughly $299 million.
- [By David Sterman]
Although shares of Boulder Brands (Nasdaq: BDBD) are up more than 60% since then, Home Loan Servicing (Nasdaq: HLSS) has merely treaded water while Swift Energy has continued its downward ascent.
Best Logistics Stocks To Own Right Now: Hospira Inc (HSP)
Hospira, Inc. (Hospira), incorporated on September 16, 2003, is a provider of injectable drugs and infusion technologies. Hospira's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira's portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities. Hospira conducts operations worldwide and is managed in three reportable segments: Americas; Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment includes the United States, Canada and Latin America; the EMEA segment includes Europe, the Middle East and Africa, and the APAC segment includes Asia, Japan, Australia and New Zealand. In all segments, Hospira sells a line of products, including specialty injectable and other pharmaceuticals and medication management products.
Specialty Injectable Pharmaceuticals
Hospira's specialty injectable pharmaceutical products consist of generic injectable pharmaceuticals. The other drugs' therapeutic areas include analgesia, anesthesia, anti-infectives, cardiovascular, oncology, and other areas. All of Hospira's generic injectable pharmaceuticals in the United States include unit-of-use bar-code labels that can be used to support medication delivery. Hospira primarily procures the active pharmaceutical ingredients in these products from third-party suppliers. During the year ended December 31, 2011, Hospira portfolio included 87 injectable drug launches consisting of 13 compounds. Among these launches included, in the United States, docetaxel (an oncolytic drug used to treat a variety of cancers), topotecan (an oncolytic drug used for the treatment of small cell lung cancer) and imipenem-cilastatin (a beta-lactam antibiotic). Hospira also launched a solution formulation of gemcitabine (an oncolytic drug used to treat a variety of cancers), which augmented Hospira's portfolio of gemcitabin! e products. New-to-country launches in EMEA in 2011, included topotecan, meropenem, gemcitabine, imipenem-cilastatin, remifentanil, docetaxel and levofloxacin. New-to-country launches in APAC in 2011, included docetaxel, piperacillin tazobactam, oxaliplatin, meropenem and gemcitabine. Hospira's specialty injectable pharmaceutical products also include Precedex (dexmedetomidine HCl), a sedative. Precedex is licensed to Hospira by Orion Corporation in the Americas and APAC segments, and in the Middle East and Africa.
Hospira sells and markets Precedex for use in non-intubated patients requiring sedation, as well as intubated and mechanically ventilated patients. Hospira's specialty injectable pharmaceuticals also include biologic products, which are molecules derived from cells that are demonstrated to be similar to an approved originator product. Hospira's biosimilar, Retacrit, was available in 20 EMEA countries during 2011. Its second biosimilar, Nivestim, was launched during the year ended December 31, 2010, and was available in 21 countries, including Australia, where the biosimilar filgrastim product was launched in 2011. Hospira's drug delivery formats include offerings in ampules and flip-top vials, which clinicians can use with standard syringes. Hospira's drug delivery options include Carpuject and iSecure prefilled syringes, AnsyrTM prefilled needleless emergency syringe systems, First Choice ready-to-use premix and the ADD-Vantage system for preparing drug solutions from prepackaged drug powders or concentrates.
Other Pharmaceuticals
Hospira's other pharmaceuticals primarily consist of intravenous (I.V.) solutions, nutritionals and contract manufacturing services. Hospira offers infusion therapy solutions and related supplies that include I.V. solutions for general use, I.V. nutrition products, and solutions for the washing and cleansing of wounds or surgical sites. All of Hospira's injectable I.V. solutions in the United States include unit-of-use bar-c! ode label! s that can be used to support medication management efforts. Hospira also offers infusion therapy solutions in its VisIV non-PVC, non-DEHP I.V. container, an I.V. bag. Hospira's contract manufacturing services are offered through its One2One services group, which provides formulation development, filling and finishing of injectable and oral drugs worldwide. Hospira works with its pharmaceutical and biotechnology customers to develop injectable forms of their drugs, and Hospira fills and finishes those and other drugs into containers and packaging selected by the customer. The customer then sells the finished products under its own label. Hospira's One2One manufacturing services group generally does not manufacture active pharmaceutical ingredients, but offers a range of filling and finishing services in a variety of delivery systems.
Medication Management
Medication management products include electronic drug delivery pumps, safety software and disposable administration sets dedicated to Hospira pumps. These sets are used to deliver I.V. fluids and medications. Hospira also offers software maintenance agreements and other service offerings. Hospira's electronic drug delivery pumps include Hospira's general infusion system, Symbiq; the Plum A+ line of infusion pumps; Hospira's patient-controlled analgesia device, LifeCare PCA; the GemStar ambulatory infusion pump; and the Plum XLD infusion pump. Hospira offers the Hospira MedNet safety software system, which has been designed to enable hospitals to customize intravenous drug dosage limits and track drug delivery to prevent medication errors. The wireless network version of the Hospira MedNet system establishes real-time send-and-receive capability and can interface with select hospital and pharmacy information systems. The Hospira MedNet system is standard in the Symbiq infusion system, and is also available as an additional feature for the Plum A+ line, and LifeCare PCA devices. Hospira also offers safety software with its Ge! mStar pum! p.
Medication management includes TheraDoc, Inc. products, which are module-based clinical surveillance systems that provide patient safety surveillance and clinical decision support. Medication management also includes gravity administration sets and other device products, including needlestick safety products and programs to support Hospira's customers' needlestick prevention initiatives. LifeShield CLAVE and LifeShield MicroCLAVE connectors are one-piece valves that directly connect syringes filled with medications to a patient's I.V. line without the use of needles. ICU Medical's CLAVE connectors are a component of administration sets sold by Hospira to its customers in the United States and select markets outside the United States.
The Company competes with Baxter International Inc., Boehringer Ingelheim, Fresenius Kabi, Pfizer, Sandoz, Sanofi, Teva Pharmaceuticals, B. Braun Melsungen AG, CareFusion, Terumo, Actavis, Intas Pharmaceuticals, Ltd, Medac GmbH, Mylan Inc., Sun Pharmaceutical Industries, Ltd. and Aspen.
Advisors' Opinion:- [By Saumya Vaishampayan]
Hospira Inc. (HSP) �shares gained 7%. The company on Wednesday posted a 58% surge in third-quarter profit as revenue edged up 1.4%, with adjusted profit and sales beating expectations.
Best Logistics Stocks To Own Right Now: Katy Industries Inc (KATY)
Katy Industries, Inc. (Katy) is a manufacturer, importer and distributor of commercial cleaning and storage products. The Company�� commercial cleaning products are sold primarily to janitorial/sanitary and foodservice distributors that supply end users, such as restaurants, hotels, healthcare facilities and schools. The Company�� storage products are primarily sold through home improvement and mass market retail outlets. Continental Commercial Products, LLC (CCP) is its wholly owned subsidiary and includes as divisions all of its business units. The Company�� business units are Continental, Contico, Container, Gemtex, Glit and Wilen. On October 4, 2011, the Company sold all assets and certain liabilities related to the DISCO division of CCP to DISCO Acquisition Corp. In February 2014, Katy Industries Inc completed the acquisition of Fort Wayne Plastics, Inc.
The Continental business unit is a plastics manufacturer and an importer and distributor of products for the commercial janitorial/sanitary maintenance, industrial and food service markets. Continental products include commercial waste receptacles, buckets, mop wringers, janitorial carts, and other products designed for commercial cleaning and food service. Continental products are sold under the brand names, such as Continental, Kleen Aire, Huskee, SuperKan, King Kan, Unibody, Tilt-N-Wheel, Wall Hugger, Collossus, Corner��Round, Rountop, Swingline, Kleen Tech and Structo Tuff.
The Contico business unit is a plastics manufacturer and distributor of home and tool storage products, sold primarily through home improvement and mass market retail outlets. Contico products include plastic home storage units, such as domestic storage containers, tool boxes, shelving and hard plastic gun cases and are sold under the brand names Contico and Tuffbin. Contico is a registered trademark used under license from Contico Manufacturing Limited.
The Container business unit is a plastics manufacturer and distributor ! of industrial storage drums and pails for commercial and industrial use. Products are sold under the Contico and Contico Container brand names.
The Gemtex business unit is a manufacturer and distributor of resin fiber disks and other coated abrasives for the original equipment manufacturer (OEM), automotive, industrial and home improvement markets. Gemtex products are sold under the brand names Trim-Kut and Grind R.
The Glit business unit is a manufacturer and distributor of non-woven abrasive products for commercial and industrial use and also supplies materials to various OEMs. Glit non-woven products include floor maintenance pads, hand pads, scouring pads, specialty abrasives for cleaning and finishing, growth medium and roof ventilation products. These products are sold primarily in the commercial sanitary maintenance, food service, industrial and construction markets under the brand names, such as Glit, Kleenfast, Glit/Microtron, Fiber Naturals, Blue Ice, Brillo, Cyclone, Cyclone D, Sponge Pro, Wipe Clean Pro, Joey, Jackeroo, Buckaroo, Cocopad, Safire and WalnutPad. Brillo is a registered trademark used under license from Armaly Brands, Inc. and BAB-O is a registered trademark used under license from Fitzpatrick Bros., Inc.
The Wilen business unit is a manufacturer, importer and distributor of professional cleaning products that include mops, brooms, brushes and plastic cleaning accessories. Wilen products are sold primarily through commercial sanitary maintenance, industrial and food service markets, with some products sold through consumer retail outlets. Products are sold under the brand names, such as Wilen, Wax-o-matic, Rototech, ErgoWorx and Derma-Tek.
Advisors' Opinion:- [By Chris Mydlo]
The guru, Mario Gabelli, purchased 724,729 shares of Katy Industries (KATY). According to the 13D filed with the SEC on March 21, 2014, Gabelli is deemed to have beneficial ownership of the securities owned by Gabelli Funds, GAMCO, Teton Advisors and MJG Associates. The total amount of shares owned is 1,711,045, representing 21.52% of the shares outstanding. Katy engages in the manufacture, import and distribution of commercial cleaning and storage products for commercial janitorial/sanitary maintenance, industrial, foodservice, mass merchant retail and home improvement markets in the U.S., Canada and Europe.
Best Logistics Stocks To Own Right Now: Celsius Holdings Inc (CELH)
Celsius Holdings, Inc., incorporated on April 26, 2005, is engaged in the development, marketing, sale and distribution of functional calorie-burning beverages under the Celsius brand name. The Company focuses to combine nutritional science with mainstream beverages by using its thermogenic (calorie-burning) MetaPlus formulation. The Company does not directly manufacture its beverages, but instead outsource the manufacturing process to established third-party co-packers. The Company provides its co-packers with flavors, ingredient blends, cans and other raw materials for its beverages purchased by the Company from various suppliers. Celsius, Inc. and Elite FX, Inc. are the wholly owned subsidiaries of the Company.
The Company�� Celsius is a calorie-burning beverage. Celsius is available in seven flavors, lemon-lime, ginger ale, cola, orange and wild berry (which are carbonated) and non-carbonated green tea raspberry/acai and green tea/peach mango. Its beverages are sold in 12 ounce cans, although it has begun to market the ingredients in powdered form in individual On-The-Go packets. The Company�� customer�� include on-the-go women, age 25 to 54, who are looking for a way to burn calories and gain energy with beverages and natural alternatives to diet sodas, as well as sports enthusiasts of both sexes, who are seeking low sodium, preservative-free alternatives. During the year ended December 31, 2009, the Company developed its MetaPlus formulation into a powder that can be mixed with water.
The Company competes with The Coca-Cola Company, Dr. Pepper Snapple Group, PepsiCo, Inc., Nestl茅, Waters North America, Inc., Hansen Natural Corp., and Red Bull.
Advisors' Opinion:- [By John Udovich]
Monster Beverage Corp (NASDAQ: MNST), a mid cap marketer and distributor of energy drinks and alternative beverages, has been a monster of a performer since the end of the financial crisis as the stock is up around 308% over the past five years, but could new or overlooked players like small cap beverage stocks�Jones Soda Co (OTCMKTS: JSDA), Celsius Holdings, Inc (OTCMKTS: CELH) and Konared Corp (OTCBB: KRED) repeat that performance? A look strictly at the long term performance of all three small caps might have you thinking otherwise. After all, none of these small cap beverage stocks are profitable while�the beverage industry can be a long hard expensive slog just to increase market share by one or two points when you are competing for shelf space with industry giants like Pepsi and Coke. But past performance is just that���the past and only part of the story as there is much more to consider about these small cap beverage stocks which could also make them potential acquisition targets by larger beverage players seeking to expand their product line up with innovative products:
Best Logistics Stocks To Own Right Now: CareFusion Corp (CFN)
CareFusion Corporation (CareFusion), incorporated on January 14, 2009, is a global medical technology company. The Company operates in two segments: Medical Systems and Procedural Solutions. The Medical Systems segment is organized around its medical equipment businesses. The Company�� Medical Systems segment�� business units and product lines include Infusion Systems, Dispensing Technologies, and Respiratory Technologies. The Procedural Solutions segment is organized around the Company�� disposable products and reusable surgical instruments businesses. The Company�� Procedural Solutions segment�� business units and product lines include Infection Prevention, Medical Specialties and Specialty Disposables. In August 2011, the Company acquired Rowa. In June 2012, the Company acquired U.K. Medical Limited. In July 2012, Natus Medical, Inc. acquired the Nicolet neurodiagnostic business from CareFusion. Effective December 31, 2013, CareFusion Corp acquired Vital Signs Inc from GE Healthcare, a unit of General Electric Co.
Medical Systems Segment
The Company�� develops, manufactures and markets capital equipment and related supplies for medication management, which includes its infusion and medication dispensing technologies, supply dispensing technologies and respiratory technologies. Its products are designed to enable healthcare professionals to improve patient safety by reducing medication errors and improving administrative controls, while simultaneously improving workflow and increasing operational efficiency. The Company sells these products primarily through its direct sales force, but use third-party distributors as well, particularly outside the United States. Many of its products in this segment are integrated with other information systems within the hospital, including financial and business systems that support patient admissions, discharges and transfers, operational systems that include inventory management and clinical systems that include pharmacy inf! ormation and electronic medical records.
The Company offers value-added services and programs, software technical services and clinical education, which are designed to enhance its customers��utilization of its medical equipment products. The Company�� project management, field service organization and customer call centers support its customers before, during and after product installation. The Company�� project management teams assist customers with the development of project implementation plans, which are designed to ensure rapid, seamless implementation of its products. The Company�� field service organization provides on-site expertise to resolve customers��service issues. The Company�� customer call centers provide additional support to its customers.
The Company is engaged in designing, developing and marketing of IV infusion systems that deliver medications and other fluids directly into a patient�� veins in precise, measured quantities over a range of infusion rates. The Company is provider of point-of-care systems that automate the dispensing of medications and supplies in hospitals and other healthcare facilities in the United States. The Company develops, manufactures, markets and services mechanical ventilators and associated consumables for patients with respiratory disorders.
The Company competes with Baxter International, B. Braun, Fresenius Kabi, Hospira, Omnicell, McKesson; Drager, and MAQUET.
Procedural Solutions Segment
The Procedural Solutions segment is organized around its disposable products and reusable surgical instruments businesses. In its Procedural Solutions segment, the Company develops, manufactures and markets single-use skin antiseptic and other patient-preparation products, non-dedicated IV infusion administration sets and accessories, reusable surgical instruments and non-dedicated ventilator circuits and other disposables used for providing respiratory therapy. The products in this segm! ent are u! sed in the operating room, interventional suites, and in the critical care departments of hospitals. The Company sells these products and services through a combination of direct sales representatives and third-party distributors.
The Company�� Infection Prevention business unit consists mainly of single-use medical products used in surgical and vascular access procedures, including skin preparation products and disposable IV infusion administration sets and accessories. The Company�� Medical Specialties business unit consists mainly of specialty medical devices used in delivering interventional care and reusable surgical instrumentation products. The Company�� Specialty Disposables business unit focuses on providing clinicians with respiratory consumable products that work either independently or in conjunction with its range of ventilators.
The Company competes with 3M, ICU Medical, Becton, Dickinson, Baxter International, B. Braun; Hospira; Smiths Medical; CR Bard, Integra Life Sciences, and Teleflex.
Advisors' Opinion:- [By Anna Prior]
General Electric Co.(GE) agreed to sell the so-called Vital Signs segment of its health-care operation to CareFusion Corp.(CFN) (CFN) for $500 million.
- [By John Udovich]
Overlooked mid cap medical�technology and systems�stock CareFusion Corporation (NYSE: CFN) could offer nice growth in the healthcare space, meaning its worth taking a closer look at the stock along with the performance of potential benchmarks like the iShares Dow Jones US Medical Device ETF (NYSEARCA: IHI) and SPDR S&P Health Care Equipment ETF (NYSEARCA: XHE). I should mention that we have recently added CareFusion Corporation to our SmallCap Network Elite Opportunity (SCN EO) portfolio because the�stock continues to be in a long-term thrusting patter and we believe its also�undervalued based on current valuation.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CareFusion (NYSE: CFN ) , whose recent revenue and earnings are plotted below.
No comments:
Post a Comment